[New AT1-blocker is approved; "me too" or progress?].
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D017046:Cost Savings; D017277:Drug Approval; D005858:Germany; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D007093:Imidazoles / Q000191:economics / Q000627:therapeutic use*; D000068557:Olmesartan Medoxomil; D013777:Tetrazoles / Q000191:economics / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; D000068557:Olmesartan Medoxomil